In March 2025, the company announced new designs for just a direct-to-shopper giving of its Wegovy weight loss drug. The company recognized a fresh pharmacy, known as NovoCare, which might demand consumers $499 a month for access to the drug, lower than half the price of the drug as a result of other pharmaceutical distribution networks.[53]At the